Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteers

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 400-405

  Boni, Joseph P ^a   DeCleene, Sheryl A ^b   Cevallos, William H ^b   Hicks, David R ^b   Korth Bradley, Joan M ^b,c  

^a WYETH AYERST RESEARCH   (United States)

^b PFIZER INC   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; AGING; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LEUKOPENIA; MALE; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SEX DIFFERENCE;

EID: 0030975529     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100402     Document Type: Article

References (19)

1. Schmucker D, Wang R. The effect of aging on digestive processes. In: Masoro E, ed. CRC handbook on aging - biological sciences. Vol 3. West Palm Beach, FL: CRC Press, 1981:235-65.
2. Schmucker D. Age-related changes in drug disposition. Pharmacol Rev 1979;30:445-6.
3. Schmucker D. Aging and drug disposition. In: Rothstein M, ed. Review of biological research in aging. New York: AL Liss, 1983:381-403.
4. Reidenberg M. Drugs in the elderly. Bull N Y Acad Med 1980;56:287-94.
5. Schmucker DL. Aging and drug disposition. Phamacol Rev 1985;37:133-48.
6. Sancilio LF, Nolan JC, Wagner LE, Ward JW, The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung 1987;37:513-9.
7. Forbes JA, Edquist IA, Smith FG, Schwartz MD, Beaver WT. Evaluation of bromfenac, aspirin and ibuprofen in postoperative oral surgery pain. Pharmacotherapy 1991;11:64-70.
8. McQuay HJ, Carroll D, Frankland T, Harvey M, Moore A. Bromfenac, acetaminophen and placebo in orthopedic postoperative pain. Clin Pharmacol Ther 1990;47:760-6.
9. Ermer J, Burghart P, Rudnick M, Cevallos W, Fruncillo R, Berns J, et al. The effect of renal disease on bromfenac disposition (abstract). Pharm Res 1993;10(suppl):S105.
10. Bramer S, Ermer J, Hicks D, Cevallos W, Ben-Maimon C. Bromfenac pharmacokinetics in patients with chronic stable liver disease (abstract). Pharm Res 1993;10(suppl):S105.
11. Osman M, Chandrasekaran A, Warsheski J, Chan K, Scatina J, Ermer J, et al. Metabolic disposition of bromfenac in healthy volunteers. Pharm Res 1995;12(suppl):S372.
12. Winship LC, Carchman SH, Clark BC, Cannon WM, Osman M, Dunning LK, et al. Pharmacokinetics and protein binding of bromfenac, a non-narcotic analgesic, in elderly male and female subjects (abstract). Pharmacotherapy 1988;8:127.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
14. Osman MA, Dunning LK, Cheng LK, Wright GJ. Determination of bromfenac in plasma by high-performance liquid chromatography. J Chromatogr 1989;489:452-8.
15. Boudinot FD, Jusko WJ. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984;73:774-80.
16. Jusko WJ. Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ, ed. Applied pharmacokinetics: principles of therapeutic drug monitoring, Vancouver, WA: Applied Therapeutics, Inc., 1992:2-1-2-43.
17. SAS/STAT user's guide. 4th ed. Gary, NC: SAS Institute, 1990.
18. Woodhouse KW, Wynne H. The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly. Clin Pharmacokinet 1987;12:111-22.
19. Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly. An update. Clin Pharmacokinet 1989;17:236-63.